Johnson & Johnson (JNJ) released its second quarter results on Wednesday, July 21, 2021. The company reported net earnings of $2.35 per share for the second quarter ending June 30, 2021. Earnings for this past quarter were up 73 percent compared to the same period a year ago.
Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey. Johnson & Johnson researches and develops, manufactures, and sells a range of products in the health care field worldwide. It operates through three segments: Consumer Health, Pharmaceutical, and Medical Devices.
Johnson & Johnson's revenue increased 11 percent over the past trailing twelve-month period versus the previous twelve-month period. Gross margins decreased to 72.61% for the second quarter compared to the same period in the previous year, and operating margins increased to 26.84% over the same period. Net earnings for past trailing twelve months were $17767.0 million, up 17% from the prior year.
Moving on to the balance sheet, Johnson & Johnson's cash levels dropped 18% for the second quarter over the same period last year. Overall liquidity of the balance sheet, as measured by the current ratio, decreased 2.24% this past year. The current ratio for Johnson & Johnson now stands at 1.28. The company increased shares outstanding by 0.01%.
Shares of JNJ are currently trading around $169.49. In terms of valuation, the stock is trading at a trailing twelve-month price to earnings ratio of 25.48 and price to book ratio of 6.88.
_____
This article was written by Value Investing News (https://www.valueinvestingnews.com) on Thursday, July 22, 2021.